• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴结比率作为 N1b 期甲状腺乳头状癌患者分层的工具。

Lymph node ratio as a tool to stratify patients with N1b papillary thyroid cancer.

机构信息

Department of Thyroid and Neck, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.

出版信息

Langenbecks Arch Surg. 2023 Aug 16;408(1):315. doi: 10.1007/s00423-023-03033-w.

DOI:10.1007/s00423-023-03033-w
PMID:37584830
Abstract

BACKGROUND

The prognostic significance of lymph node ratio (LNR) in N1b papillary thyroid cancer is unclear. Therefore, the impact of LNR on disease-specific mortality (DSM) and overall survival (OS) in patients with N1b papillary thyroid cancer (PTC) needs to be defined.

METHODS

We used the Surveillance, Epidemiology, and End Results (SEER) database of patients who had undergone thyroidectomy and lymph node dissection. Factors associated with DSM and OS were analyzed and identified using univariate and multivariate Cox proportional risk models. X-tile software was used to find the best cutoff value of LNR. Kaplan-Meier estimates for DSM were plotted for LNR and were compared with the log-rank test. The ROC curve evaluated the validity of the model.

RESULTS

A total of 3223 patients with N1b PTC were identified in the SEER database between 1975 and 2019. The best cutoff value for LNR was 0.6. The multivariate Cox proportional risk model showed that age, race, T3/T4 classification, distant metastasis, extent of surgery, number of metastatic lymph nodes, and LNR > 0.6 were independent risk factors for DSM (all p < 0.05). Age, sex, T4 classification, distant metastasis, extent of surgery, and LNR > 0.6 were independent risk factors for OS (all p < 0.05). The Kaplan-Meier method plotted a cumulative risk curve and showed that patients with LNR > 0.6 had a significantly higher risk of DSM than patients with LNR ≤ 0.6 (p = 0.002).

CONCLUSION

LNR was a powerful predictor of DSM and OS in N1b PTC patients. LNR could be a useful tool for the stratification of PTC patients with lateral neck metastases.

摘要

背景

淋巴结比值(LNR)在 N1b 型甲状腺乳头状癌中的预后意义尚不清楚。因此,需要确定 LNR 对 N1b 型甲状腺乳头状癌(PTC)患者疾病特异性死亡率(DSM)和总生存率(OS)的影响。

方法

我们使用了接受甲状腺切除术和淋巴结清扫术的患者的监测、流行病学和最终结果(SEER)数据库。使用单变量和多变量 Cox 比例风险模型分析并确定与 DSM 和 OS 相关的因素。X-tile 软件用于找到 LNR 的最佳截断值。绘制 LNR 的 DSM 的 Kaplan-Meier 估计值,并与对数秩检验进行比较。ROC 曲线评估模型的有效性。

结果

在 1975 年至 2019 年期间,SEER 数据库中确定了 3223 例 N1b PTC 患者。LNR 的最佳截断值为 0.6。多变量 Cox 比例风险模型显示,年龄、种族、T3/T4 分类、远处转移、手术范围、转移淋巴结数量和 LNR>0.6 是 DSM 的独立危险因素(均 p<0.05)。年龄、性别、T4 分类、远处转移、手术范围和 LNR>0.6 是 OS 的独立危险因素(均 p<0.05)。Kaplan-Meier 方法绘制了累积风险曲线,表明 LNR>0.6 的患者 DSM 的风险明显高于 LNR≤0.6 的患者(p=0.002)。

结论

LNR 是 N1b PTC 患者 DSM 和 OS 的有力预测指标。LNR 可能是用于分层有侧颈部转移的 PTC 患者的有用工具。

相似文献

1
Lymph node ratio as a tool to stratify patients with N1b papillary thyroid cancer.淋巴结比率作为 N1b 期甲状腺乳头状癌患者分层的工具。
Langenbecks Arch Surg. 2023 Aug 16;408(1):315. doi: 10.1007/s00423-023-03033-w.
2
Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.颈侧区淋巴结转移的儿童甲状腺癌中预测复发风险的淋巴结比值和转移淋巴结大小的最佳值。
J Pediatr Surg. 2023 Mar;58(3):568-573. doi: 10.1016/j.jpedsurg.2022.07.010. Epub 2022 Jul 13.
3
Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.淋巴结比率可预测儿童乳头状甲状腺癌的复发情况。
J Pediatr Surg. 2019 Jan;54(1):129-132. doi: 10.1016/j.jpedsurg.2018.10.010. Epub 2018 Oct 5.
4
Impact of lymph node ratio on survival in papillary thyroid cancer.淋巴结比率对甲状腺乳头状癌生存的影响。
Ann Surg Oncol. 2013 Jun;20(6):1906-11. doi: 10.1245/s10434-012-2802-8. Epub 2012 Dec 23.
5
Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size.通过侧方淋巴结比率和最大淋巴结大小对 N1b 期甲状腺乳头状癌的生存预后进行再分层。
Cancer Med. 2017 Oct;6(10):2244-2251. doi: 10.1002/cam4.1160. Epub 2017 Aug 31.
6
Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes.侧颈部淋巴结比率是甲状腺乳头状癌伴淋巴结转移患者无复发生存的独立危险因素。
Endocrine. 2022 Dec;78(3):484-490. doi: 10.1007/s12020-022-03173-x. Epub 2022 Aug 26.
7
Risk factors for level V metastasis in patients with N1b papillary thyroid cancer.N1b 期甲状腺乳头状癌患者发生 V 区转移的危险因素。
World J Surg Oncol. 2022 Sep 30;20(1):327. doi: 10.1186/s12957-022-02782-0.
8
Analysis of factors associated with the prognosis of papillary thyroid cancer and the construction of a survival model.分析影响甲状腺乳头状癌预后的相关因素并构建生存模型。
Cancer Med. 2023 Apr;12(7):7868-7876. doi: 10.1002/cam4.5555. Epub 2022 Dec 22.
9
Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma.评估中央淋巴结比值在预测 N1a 低-中危甲状腺乳头状癌复发中的作用。
Front Endocrinol (Lausanne). 2023 Sep 14;14:1158826. doi: 10.3389/fendo.2023.1158826. eCollection 2023.
10
How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.需要切除多少个淋巴结?淋巴结比值小于 1/3 可降低甲状腺乳头状癌的淋巴结复发率。
Laryngoscope. 2022 Sep;132(9):1883-1887. doi: 10.1002/lary.30084. Epub 2022 Mar 1.

引用本文的文献

1
Pathological metastatic lymph node density (ND) predicts early recurrence in papillary thyroid cancer patients after curative resection.病理性转移性淋巴结密度(ND)可预测甲状腺乳头状癌患者根治性切除术后的早期复发。
Gland Surg. 2025 May 30;14(5):897-911. doi: 10.21037/gs-2025-36. Epub 2025 May 15.

本文引用的文献

1
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.甲状腺癌临床实践指南(NCCN 指南)2022 年第 2 版。
J Natl Compr Canc Netw. 2022 Aug;20(8):925-951. doi: 10.6004/jnccn.2022.0040.
2
Inclusion of the Number of Metastatic Lymph Nodes in the Staging System for Medullary Thyroid Cancer: Validating a Modified American Joint Committee on Cancer Tumor-Node-Metastasis Staging System.包含转移淋巴结数量的甲状腺髓样癌分期系统:验证改良的美国癌症联合委员会肿瘤-淋巴结-转移分期系统。
Thyroid. 2022 May;32(5):536-543. doi: 10.1089/thy.2021.0571. Epub 2022 May 3.
3
Cancer Statistics, 2021.
癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
4
Association of Lymph Node Ratio With Overall Survival in Patients With Metastatic Papillary Thyroid Cancer.淋巴结比率与转移性甲状腺乳头状癌患者总生存的关联。
JAMA Otolaryngol Head Neck Surg. 2020 Oct 1;146(10):962-964. doi: 10.1001/jamaoto.2020.2053.
5
Thyroid Cancer Incidence Trends in the United States: Association with Changes in Professional Guideline Recommendations.美国甲状腺癌发病率趋势:与专业指南建议变化的关联。
Thyroid. 2020 Aug;30(8):1132-1140. doi: 10.1089/thy.2019.0415. Epub 2020 Apr 3.
6
Investigating the prevalence of risk factors of papillary thyroid carcinoma recurrence and disease-free survival after thyroidectomy and central neck dissection in Iranian patients.调查伊朗患者甲状腺切除术后和中央颈部清扫术后乳头状甲状腺癌复发和无病生存的风险因素的流行情况。
Acta Chir Belg. 2020 Jun;120(3):173-178. doi: 10.1080/00015458.2019.1576447. Epub 2019 Jun 25.
7
Lymph node density in papillary thyroid carcinoma is a prognostic factor after adjusting for pathological stage.在对病理分期进行校正后,甲状腺乳头状癌中的淋巴结密度是一个预后因素。
Oncotarget. 2018 Jun 1;9(42):26670-26678. doi: 10.18632/oncotarget.25453.
8
Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis.第八版 AJCC TNM 分类和伴有侧方淋巴结转移的甲状腺乳头状癌预后分组的修订。
Oral Oncol. 2018 Mar;78:80-86. doi: 10.1016/j.oraloncology.2018.01.021. Epub 2018 Feb 20.
9
Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size.通过侧方淋巴结比率和最大淋巴结大小对 N1b 期甲状腺乳头状癌的生存预后进行再分层。
Cancer Med. 2017 Oct;6(10):2244-2251. doi: 10.1002/cam4.1160. Epub 2017 Aug 31.
10
Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.颈侧区淋巴结转移(N1b)是甲状腺乳头状癌预后的另一个危险因素。
J Endocrinol Invest. 2017 Dec;40(12):1355-1363. doi: 10.1007/s40618-017-0714-y. Epub 2017 Jun 23.